|
[1]CHALASANI N, YOUNOSSI Z, LAVINE JE, et al.The diagnosis and management of non-alcoholic fatty liver disease:Practice guideline by the American Association for the Study of Liver Disea-ses, American College of Gastroenterology, and the American Gas-troenterological Association[J].Gastroenterology, 2012, 142 (7) :1592-1609.
|
|
[2]WU T, YIN SY, WANG HC, et al.The clinical features and risk factors of patients with metabolic syndrome combined with non-al-coholic fatty liver diseases[J].J Clin Hepatol, 2011, 27 (10) :1036-1040. (in Chinese) 吴涛, 尹守乙, 王宏长, 等.代谢综合征合并非酒精性脂肪性肝病患者的临床特点和危险因素[J].临床肝胆病杂志, 2011, 27 (10) :1036-1040.
|
|
[3]VERNON G, BARANOVA A, YOUNOSSI ZM.Systematic review:the epidemiology and natural history of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in adults[J].Aliment Pharmacol Ther, 2011, 34 (3) :274-285.
|
|
[4]ROCKEY DC, CALDWELL SH, GOODMAN ZD, et al.Liver bi-opsy[J].Hepatology, 2009, 49 (3) :1017-1044.
|
|
[5]POYNARD T, RATZIU V, CHARLOTTE F, et al.Diagnostic val-ue of biochemical markers (NashTest) for the prediction of non al-coholo steato hepatitis in patients with non-alcoholic fatty liver dis-ease[J].BMC Gastroenterol, 2006, 6:34.
|
|
[6]FELDSTEIN AE, CANBAY A, ANGULO P, et al.Hepatocyte ap-optosis and fas expression are prominent features of human nonalco-holic steatohepatitis[J].Gastroenterology, 2003, 125 (2) :437-443.
|
|
[7]WIECKOWSKA A, ZEIN NN, YERIAN LM, et al.In vivo assess-ment of liver cell apoptosis as a novel biomarker of disease severityin nonalcoholic fatty liver disease[J].Hepatology, 2006, 44 (1) :27-33.
|
|
[8]FELDSTEIN AE, WIECKOWSKA A, LOPEZ AR, et al.Cytokera-tin-18fragment levels as noninvasive biomarkers for nonalcoholic steatohepatitis:a multicenter validation study[J].Hepatology, 2009, 50 (4) :1072-1078.
|
|
[9]DIAB DL, YERIAN L, SCHAUER P, et al.Cytokeratin18frag-ment levels as a noninvasive biomarker for nonalcoholic steatohepati-tis in bariatric surgery patients[J].Clin Gastroenterol Hepatol, 2008, 6 (11) :1249-1254.
|
|
[10]MUSSO G, GAMBINO R, CASSADER M, et al.Meta-analysis:natural history of non-alcoholic fatty liver disease (NAFLD) and diagnostic accuracy of non-invasive tests for liver disease severity[J].Ann Med, 2011, 43 (8) :617-649.
|
|
[11]STAUB F, TOURNOUX-FACON C, ROUMY J, et al.Liver fi-brosis staging with contrast-enhanced ultrasonography:prospective multicenter study compared with METAVIR scoring[J].Eur Radi-ol, 2009, 19 (8) :1991-1997.
|
|
[12]IIJIMA H, MORIYASU F, TSUCHIYA K, et al.Decrease in accumu-lation of ultrasound contrast microbubbles in non-alcoholic steatohepa-titis[J].Hepatol Res, 2007, 37 (9) :722-730.
|
|
[13]HARRISON SA, OLIVER D, ARNOLD HL, et al.Development and validation of a simple NAFLD clinical scoring system for identif-ying patients without advanced disease[J].Gut, 2008, 57 (10) :1441-1447.
|
|
[14]ANGULO P, HUI JM, MARCHESINI G, et al.The NAFLD fibrosis score:a noninvasive system that identifies liver fibrosis in patients with NAFLD[J].Hepatology, 2007, 45 (4) :846-854.
|
|
[15]QURESHI K, CLEMENTS RH, ABRAMS GA.The utility of the“NAFLD fibrosis score”in morbidly obese subjects with NAFLD[J].Obes Surg, 2008, 18 (3) :264-270.
|
|
[16]RUFFILLO G, FASSIO E, ALVAREZ E, et al.Comparison of NAFLD fibrosis score and BARD score in predicting fibrosis in non-alcoholic fatty liver disease[J].J Hepatol, 2011, 54 (1) :160-163.
|
|
[17]McPHERSON S, STEWART SF, HENDERSON E, et al.Simple non-invasive fibrosis scoring systems can reliably exclude advanced fibrosis in patients with non-alcoholic fatty liver disease[J].Gut, 2010, 59 (9) :1265-1269.
|
|
[18]HALFON P, MUNTEANU M, POYNARD T.FibroTest-ActiTestas a non-invasive marker of liver fibrosis[J].Gastroenterol Clin Biol, 2008, 32 (6Suppl1) :22-39.
|
|
[19]POYNARD T, MORRA R, HALFON P, et al.Meta-analyses of FibroTest diagnostic value in chronic liver disease[J].BMC Gastro-enterol, 2007, 7:40.
|
|
[20]MUNTEANU M, RATZIU V, MORRA R, et al.Noninvasive bio-markers for the screening of fibrosis, steatosis and steatohepatitis in patients with metabolic risk factors:FibroTest-FibroMax experi-ence[J].J Gastrointestin Liver Dis, 2008, 17 (2) :187-191.
|
|
[21]GUHA IN, PARKES J, RODERICK P, et al.Noninvasive markers of fibrosis in nonalcoholic fatty liver disease:Validating the European Liv-er Fibrosis Panel and exploring simple markers[J].Hepatology, 2008, 47 (2) :455-460.
|
|
[22]PARKES J, RODERICK P, HARRIS S, et al.Enhanced liver fi-brosis test can predict clinical outcomes in patients with chronic liver disease[J].Gut, 2010, 59 (9) :1245-1251.
|
|
[23]SANDRIN L, TANTER M, CATHELINE S, et al.Shear modulus imaging with2-D transient elastography[J].IEEE Trans Ultrason Ferroelectr Freq Control, 2002, 49 (4) :426-435.
|
|
[24]TAN YJ, JI D, NIU XX, et al.Frequency and determinants of liver stiffness measurement failure[J].J Med Res, 2012, 41 (11) :30-33. (in Chinese) 谭有娟, 纪冬, 牛小霞, 等.瞬时弹性成像检测肝硬度失败的因素及分析[J].医学研究杂志, 2012, 41 (11) :30-33.
|
|
[25]YONEDA M, FUJITA K, INAMORI M, et al.Transient elastogra-phy in patients with non-alcoholic fatty liver disease (NAFLD) [J].Gut, 2007, 56 (9) :1330-1331.
|
|
[26]WONG VW, VERGNIOL J, WONG GL, et al.Diagnosis of fibrosis and cirrhosis using liver stiffness measurement in nonalcoholic fatty liver disease[J].Hepatology, 2010, 51 (2) :454-462.
|
|
[27]de LéDINGHEN V, VERGNIOL J, FOUCHER J, et al.Feasibility of liver transient elastography with FibroScan using a new probe for obese patients[J].Liver Int, 2010, 30 (7) :1043-1048.
|
|
[28]PALMERI ML, WANG MH, ROUZE NC, et al.Noninvasive eval-uation of hepatic fibrosis using acoustic radiation force-based shear stiffness in patients with nonalcoholic fatty liver disease[J].J Hep-atol, 2011, 55 (3) :666-672.
|
DownLoad: